Utilization of oncotype DX in node-negative, ER-positive breast cancer patients

被引：0
|
作者：
Patel, H. [1 ]
Hook, K. [1 ]
Kaplan, C. [1 ]
Davidson, R. [1 ]
DeMichele, A. [1 ]
Fox, K. R. [1 ]
Domchek, S. M. [1 ]
机构：
[1] Abramson Canc Ctr, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11067
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Oncotype DX Breast Recurrence Score®: Real-life utilization among node positive patients in Ontario
    Richardson, Roy
    Macchiusi, Amanda
    Bhasin, Ashwini
    Takizawa, Claire
    CANCER RESEARCH, 2018, 78 (04)
  • [32] How Much Is Oncotype DX Recurrence Score Impacting the Adjuvant Treatment Management of Node-Negative Early-Stage Breast Cancer Patients?
    Nguyen, M. T.
    Chen, Z.
    D'Alfonso, T.
    Stessin, A.
    Nagar, H.
    Hayes, M.
    Shin, S. J.
    MODERN PATHOLOGY, 2013, 26 : 59A - 59A
  • [33] Implementation of Oncotype Dx to Guide Chemotherapy Sparing for Women with Postmenopausal N1-3, ER-positive, HER-2-negative Breast Cancer
    Rajakumar, L.
    Glendenning, J.
    Hall, J.
    Burcombe, R.
    McCormick, G.
    Hegarty, G.
    Harper-Wynne, C.
    Brown, B.
    Moss, C.
    Thomas, C.
    Jyothirmayi, R.
    Osman, M.
    Nikiforidis, L.
    CLINICAL ONCOLOGY, 2024, 36 (04) : E111 - E111
  • [34] How Much Is Oncotype DX Recurrence Score Impacting the Adjuvant Treatment Management of Node-Negative Early-Stage Breast Cancer Patients?
    Nguyen, M. T.
    Chen, Z.
    D'Alfonso, T.
    Stessin, A.
    Nagar, H.
    Hayes, M.
    Shin, S. J.
    LABORATORY INVESTIGATION, 2013, 93 : 59A - 59A
  • [35] Interleukin-8 in progression of ER-positive and ER-negative breast cancer patients
    Todorovic-Rakovic, N.
    Milovanovic, J.
    Abu Rabi, Z.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S115 - S115
  • [36] Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast Cancer
    Poorvu, Philip D.
    Gelber, Shari, I
    Rosenberg, Shoshana M.
    Ruddy, Kathryn J.
    Tamimi, Rulla M.
    Collins, Laura C.
    Peppercorn, Jeffrey
    Schapira, Lidia
    Borges, Virginia F.
    Come, Steven E.
    Warner, Ellen
    Jakubowski, Debbie M.
    Russell, Christy
    Winer, Eric P.
    Partridge, Ann H.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (07) : 725 - +
  • [37] Analytical validation of the oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancer
    Cronin, Maureen
    Sangli, Chithra
    Liu, Mei-Lan
    Pho, Mylan
    Dutta, Debjani
    Nguyen, Anhthu
    Jeong, Jennie
    Wu, Jenny
    Langone, Kim Clark
    Watson, Drew
    CLINICAL CHEMISTRY, 2007, 53 (06) : 1084 - 1091
  • [38] Preoperative Prediction of Node-Negative Disease After Neoadjuvant Chemotherapy in Patients Presenting with Node-Negative or Node-Positive Breast Cancer
    Brittany L. Murphy
    Tanya L. Hoskin
    Courtney Day N. (Heins)
    Elizabeth B. Habermann
    Judy C. Boughey
    Annals of Surgical Oncology, 2017, 24 : 2518 - 2525
  • [39] Preoperative Prediction of Node-Negative Disease After Neoadjuvant Chemotherapy in Patients Presenting with Node-Negative or Node-Positive Breast Cancer
    Murphy, Brittany L.
    Hoskin, Tanya L.
    , Courtney Day N.
    Habermann, Elizabeth B.
    Boughey, Judy C.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (09) : 2518 - 2525
  • [40] Prognostic variables in node-negative and node-positive breast cancer
    Gasparini, G
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) : 321 - 331
12345